JHEP Reports (Dec 2022)

What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer AssociationKey points

  • Manon Allaire,
  • Jordi Bruix,
  • Marko Korenjak,
  • Sarah Manes,
  • Zorana Maravic,
  • Helen Reeves,
  • Riad Salem,
  • Bruno Sangro,
  • Morris Sherman

Journal volume & issue
Vol. 4, no. 12
p. 100578

Abstract

Read online

Summary: Hepatocellular carcinoma (HCC) is a major public health problem worldwide for which the incidence and mortality are similar, pointing to the lack of effective treatment options. Knowing the different issues involved in the management of HCC, from risk factors to screening and management, is essential to improve the prognosis and quality of life of affected individuals. This document summarises the current state of knowledge and the unmet needs for all the different stakeholders in the care of liver cancer, meaning patients, relatives, physicians, regulatory agencies and health authorities so that optimal care can be delivered to patients. The document was commissioned by the International Liver Cancer Association and was reviewed by senior members, including two ex-presidents of the Association. This document lays out the recommended approaches to the societal management of HCC based on the economic status of a given region.

Keywords